Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > News > Academic oncology: women’s careers at high risk for continued inequality
  • News

Academic oncology: women’s careers at high risk for continued inequality

  • 7 January 2022
  • Janet Fricker
Gender balance in medical professions
Academic oncology: women’s careers at high risk for continued inequality
Total
0
Shares
0
0
0
0
0

More than half of women in oncology practice believe their gender adversely affects their prospects for job promotion, especially in academia. The cross-sectional survey, published in JAMA Netw Open (December 30, 2021), found that more academic female oncologists than non-academic female oncologists report a poor sense of belonging in the workplace, with one in five currently considering leaving academia.

“Given that more than 20% of female academic oncologists were considering leaving academia, gender inequality is at high risk of continuing if the culture is not addressed,” write the authors.

While enrolment of women in US medical schools has surpassed men, women are underrepresented in academic oncology. Statistics show women represent just 35.9% of the academic oncology faculty (37.1% in haematology/oncology, 30.7% in radiation oncology, 38.8% in surgical oncology, and 50% in paediatric haematology/oncology). Women are particularly underrepresented in leadership roles, occupying 31.4% of chairs in medical oncology, 17.4% in radiation oncology and 11.1% in surgical oncology. The pattern is repeated in professional oncology associations, with only seven out of 25 past presidents of the American Society of Clinical Oncology, for example, being women.

In the current study, Emily Merfield, a radiation oncology resident at the University of Wisconsin School of Medicine and Public Health, set out to identify the key factors associated with US female oncologists’ decisions to pursue academic or non-academic oncology practice and to characterise perceptions about their current careers.

The survey, distributed through email and social media, was completed by 667 female oncologists, of whom 422 (63.2%) identified as academic and 245 (36.8%) as non-academic. For the study, academic oncology practice was defined as clinical practice in a medical centre dedicated to scholarly activities (including teaching and research), as well as patient care, often in conjunction with a university or medical school; while non-academic oncology was described as hospital-based practice, community clinical practice, hybrid practice, government employment, or industry employment.

Results show:

  • More than half of respondents (54.6% academic oncologists and 50.6% non-academic oncologists) believe they were less likely than male colleagues to be promoted;
  • 92 academic oncologists (21.9%) reported that they were likely or very likely to pursue a career outside the academic setting within the next five years, with 26 (28.2%) stating they would switch to industry employment and 23 (25.0%) to community clinical practice;
  • 7.9% of academic oncologists versus 2.0% of non-academic oncologists reported rarely or never feeling a sense of belonging in their work environment (P<0.001);
  • Academic oncologists perceived that the biggest sacrifice of pursuing an academic practice was time with loved ones (42.9%), followed by money (20.1%) and pressure for academic promotion (18.0%). Non academic oncologists perceived that the biggest sacrifice of pursuing academic practice would be pressure for academic promotion (41.6%), followed by time with loved ones (22.4%);
  • 41.2% of non-academic versus 27.6% of academic oncologists believed gender had a positive or somewhat positive impact on their ability to obtain a chosen job (P=.001).
  • 23.5% of respondents reported that their spouse or partner and 26.4% that their family extremely or moderately affected their decision to pursue academic practice. The frequency did not differ between academic and non-academic oncologists.

“We found a clear dichotomy in the perception of academic and non-academic oncologists on how their gender affected their ability to obtain a chosen job,” write the authors. “This suggests that women in non-academic oncology are becoming increasingly recognised as key members of the oncologic treatment team.”

Strategies for improving recruitment and retention of female academic oncologists, suggest the authors, include reducing gender-based disparities in salary and promotion as well as developing a sense of belonging to ensure identity safety and minimize stereotype threat. “Specifically, removing visible reminders that women are not welcome and training faculty member to provide performance feedback that is free of sexism are important next steps,” write the authors.

Future studies, they suggest, should explore the association of gender perception with career length, and compare motivations for women and men behind career choices and departure from academic oncology.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • academic oncologists
  • gender equality
  • job prospects
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • News

High-fibre diets associated with improved melanoma immunotherapy response

  • 7 January 2022
  • Janet Fricker
View Post
Next Article
lung cancer screening Europe
  • Articles

Lung cancer screening: 2022 could be a turning point for Europe

  • 14 January 2022
  • Janet Fricker
View Post
You May Also Like
View Post
  • News

Study highlights need to reanalyse genomics and genetics of metastatic tumours

  • Janet Fricker
  • 27 January 2023
View Post
  • News

Current cervical cancer screening paradigm fails older women

  • Janet Fricker
  • 26 January 2023
View Post
  • News

Call-to-arms for Europe to provide essential paediatric anti-cancer medicines

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Exercise-stimulated myokine production can extend survival in advanced prostate cancer

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Five San Antonio take-aways to improve care of breast cancer patients

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Repurposed drug combination reduces risk of recurrence following surgery for colorectal cancer

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Aerobic activity to outcompete metastasis 

  • Janet Fricker
  • 2 December 2022
View Post
  • News

Ending cancer inequalities: European summit showcases new tools to inform policy

  • Anna Wagstaff
  • 30 November 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
  • AI application in diagnosis
    • 11 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.